Prosecution Insights
Last updated: October 02, 2026

Examiner: DIPERT, FORREST BLAKE

Tech Center 3700 • Art Units: 3783

This examiner grants 50% of resolved cases

Analysis

Forrest Blake Dipert has resolved 54 cases in Art Unit 3783 of Tech Center 3700. The examiner's allowance rate is 50.0%, but the interview lift is an exceptional 64.4%. This indicates that interviews are extremely powerful and can significantly increase the probability of success for this examiner. The median days to allowance is 1379, reflecting a longer prosecution timeline. The 64.4% lift is one of the most significant metrics in this profile, highlighting the value of direct dialogue.

In Tech Center 3700, practitioners should almost always conduct an interview to maximize the chances of success, as the 64.4% lift is a dominant feature of the data. This lift is a critical tool for overcoming the 50.0% baseline allowance rate. The 1379-day median to allowance is a significant duration that requires a proactive approach. While the 54 resolved cases are a smaller sample, the dramatic impact of interviews is a clear trend. Applicants should use the 64.4% lift to their advantage early in the process to navigate the 1379-day timeline more successfully. The 54 resolutions suggest that verbal communication is the most effective way to reach an allowance in Art Unit 3783.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

50.0%
Allow Rate
-20.0% vs TC avg
94
Total Applications
+64.4%
Interview Lift
1379
Avg Prosecution Days
Based on 54 resolved cases, 2023–2026

Rejection Statute Breakdown

0.7%
§101 Eligibility
23.5%
§102 Novelty
55.2%
§103 Obviousness
19.5%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17418176 DRUG RESERVOIR FOR SEPARATE STORAGE OF SUBSTANCES Final Rejection Novo Nordisk A/S
17613524 HOLDING DEVICE AND APPARATUS FOR AUTOMATED STOPCOCK ACTUATION Final Rejection Merck Patent GmbH
18390553 CONNECTOR COUPLING ASSEMBLY WITH RELIEF CUTS Final Rejection CareFusion 303, Inc.
18020385 CATHETER FOR FORMING AN INTERVASCULAR BRIDGE TO RELIEVE VESSEL COMPRESSION Final Rejection C.R. BARD, INC.
17431928 SEALANT DELIVERY APPARATUS, AND SYSTEM AND METHOD FOR PREPARING SAME, FOR USE IN A LUNG PROCEDURE Non-Final OA C.R. Bard, Inc.
17980054 ULTRASONICALLY POWERED SENSING DEVICE Non-Final OA Fresenius Medical Care Deutschland GmbH
18238588 Integrated Catheter System with Multiple Extension Sets Non-Final OA Becton, Dickinson and Company
18297133 CONTAINER FOR AN INJECTABLE MEDICAMENT Final Rejection SANOFI
17738644 SYRINGE SUPPORT AND AUTOINJECTOR Non-Final OA SANOFI-AVENTIS DEUTSCHLAND GMBH
18962169 ADAPTIVE DELIVERY PROFILES FOR AUTOMATED INSULIN DELIVERY TREATMENT SYSTEM Non-Final OA Tandem Diabetes Care, Inc
17587468 SYSTEMS AND METHODS FOR AUTOMATED INSULIN DELIVERY FOR DIABETES THERAPY Final Rejection Tandem Diabetes Care, Inc.
17395289 METHODS OF WIRELESS COMMUNICATION IN AN INFUSION PUMP SYSTEM Final Rejection Tandem Diabetes Care, Inc.
17590573 DRIVE DEVICE AND MEDICAL INFUSION PUMP Final Rejection TERUMO KABUSHIKI KAISHA
17634640 ADMINISTRATION MECHANISM FOR A MEDICAMENT DELIVERY DEVICE Final Rejection SHL MEDICAL AG
18606353 ACTIVE SMOKE FILTRATION FOR INSUFFLATION Non-Final OA Fisher & Paykel Healthcare Limited
17593521 SURGICAL GAS SUPPLY PRESSURE SENSING Non-Final OA Fisher & Paykel Healthcare Limited
17141992 ACTIVE SMOKE FILTRATION FOR INSUFFLATION Non-Final OA Fisher & Paykel Healthcare Limited
17425958 RIGID NEEDLE SHIELD REMOVER FOR AUTOINJECTOR Non-Final OA Becton Dickinson France
17440906 SYRINGE STERILIZATION VERIFICATION ASSEMBLIES AND METHODS Non-Final OA AMGEN INC.
17434009 DRUG INFUSION DEVICE WITH MULTIPLE INFUSION MODES Final Rejection MEDTRUM TECHNOLOGIES INC.
17432095 MINIATURE PATCH-TYPE INTELLIGENT CONTROL INFUSION DEVICE Final Rejection MEDTRUM TECHNOLOGIES INC.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month